News

P.E.I. will expand RSV protections for infants and more seniors this fall

With the approach of fall likely bringing the usual uptick in respiratory illness, the provincial government is boosting its ...

Beyfortus® (nirsevimab) approved in Singapore to protect all infants against RSV disease

The Health Sciences Authority (HSA) has approved Sanofi and AstraZeneca's BEYFORTUS (nirsevimab) for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in newborns and ...